These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15213841)

  • 1. Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells.
    Becker S; Simpson JC; Pepperkok R; Heinz S; Herder C; Grez M; Seifried E; Tonn T
    Thromb Haemost; 2004 Jul; 92(1):23-35. PubMed ID: 15213841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII-eGFP fusion proteins with preserved functional activity for the analysis of the early secretory pathway of factor VIII.
    Heinz S; Schüttrumpf J; Simpson JC; Pepperkok R; Nicolaes GA; Abriss D; Milanov P; Roth S; Seifried E; Tonn T
    Thromb Haemost; 2009 Nov; 102(5):925-35. PubMed ID: 19888531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis, assembly and secretion of coagulation factor VIII.
    Kaufman RJ; Pipe SW; Tagliavacca L; Swaroop M; Moussalli M
    Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S3-14. PubMed ID: 9607108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Full-Length FVIII Benefits from Its Heterogeneity - Insights into the Role of the B-Domain.
    Anzengruber J; Feichtinger M; Bärnthaler P; Haider N; Ilas J; Pruckner N; Benamara K; Scheiflinger F; Reipert BM; Malisauskas M
    Pharm Res; 2019 Apr; 36(5):77. PubMed ID: 30937539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation factor VIII D1241E polymorphism leads to a weak malectin interaction and reduction of factor VIII posttranslational modification and secretion.
    Jiang N; Xiao Y; Liu Y; Liu W; Liu S
    Exp Cell Res; 2020 Dec; 397(1):112334. PubMed ID: 33144078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.
    Pahl S; Pavlova A; Driesen J; Müller J; Pötzsch B; Oldenburg J
    Haemophilia; 2013 May; 19(3):392-8. PubMed ID: 23252674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.
    Demasi MA; de S Molina E; Bowman-Colin C; Lojudice FH; Muras A; Sogayar MC
    Mol Biotechnol; 2016 Jun; 58(6):404-14. PubMed ID: 27126696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface staining of recombinant factor VIII is reduced in apoptosis resistant BHK-21 cells.
    Ishaque A; Thrift J; Murphy JE; Konstantinov K
    J Biotechnol; 2008 Oct; 137(1-4):20-7. PubMed ID: 18703095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A.
    Roth SD; Schüttrumpf J; Milanov P; Abriss D; Ungerer C; Quade-Lyssy P; Simpson JC; Pepperkok R; Seifried E; Tonn T
    PLoS One; 2012; 7(9):e44505. PubMed ID: 22973456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum.
    Poothong J; Pottekat A; Siirin M; Campos AR; Paton AW; Paton JC; Lagunas-Acosta J; Chen Z; Swift M; Volkmann N; Hanein D; Yong J; Kaufman RJ
    Blood; 2020 May; 135(21):1899-1911. PubMed ID: 32128578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of human hematopoietic cell lines expressing factor VIII.
    Tonn T; Herder C; Becker S; Seifried E; Grez M
    J Hematother Stem Cell Res; 2002 Aug; 11(4):695-704. PubMed ID: 12201958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced biosynthesis of coagulation factor VIII through diminished engagement of the unfolded protein response.
    Brown HC; Gangadharan B; Doering CB
    J Biol Chem; 2011 Jul; 286(27):24451-7. PubMed ID: 21606503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of carbohydrate binding by LMAN1 protein provides new insight into the endoplasmic reticulum export of factors V (FV) and VIII (FVIII).
    Zheng C; Page RC; Das V; Nix JC; Wigren E; Misra S; Zhang B
    J Biol Chem; 2013 Jul; 288(28):20499-509. PubMed ID: 23709226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin.
    Pipe SW; Morris JA; Shah J; Kaufman RJ
    J Biol Chem; 1998 Apr; 273(14):8537-44. PubMed ID: 9525969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineering of coagulation factor VIII for improved secretion.
    Miao HZ; Sirachainan N; Palmer L; Kucab P; Cunningham MA; Kaufman RJ; Pipe SW
    Blood; 2004 May; 103(9):3412-9. PubMed ID: 14726380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII.
    Swaroop M; Moussalli M; Pipe SW; Kaufman RJ
    J Biol Chem; 1997 Sep; 272(39):24121-4. PubMed ID: 9305856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of recombinant blood coagulation factor VIII (FVIII) heavy and light chains and reconstitution of active form of FVIII.
    Oh SH; Lee MY; Song DW
    Exp Mol Med; 1999 Jun; 31(2):95-100. PubMed ID: 10410309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of factor VIII in recombinant and transgenic systems.
    Soukharev S; Hammond D; Ananyeva NM; Anderson JA; Hauser CA; Pipe S; Saenko EL
    Blood Cells Mol Dis; 2002; 28(2):234-48. PubMed ID: 12064919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca(2+) concentration-dependent conformational change of FVIII B-domain observed by atomic force microscopy.
    Bonazza K; Rottensteiner H; Schrenk G; Fiedler C; Scheiflinger F; Allmaier G; Turecek PL; Friedbacher G
    Anal Bioanal Chem; 2015 Aug; 407(20):6051-6. PubMed ID: 26001809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The B-domain of Factor VIII reduces cell membrane attachment to host cells under serum free conditions.
    Kolind MP; Nørby PL; Flintegaard TV; Berchtold MW; Johnsen LB
    J Biotechnol; 2010 Jun; 147(3-4):198-204. PubMed ID: 20438774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.